Item 2. Management’s Discussion and Analysis
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This
information should be read in conjunction with the financial statements and notes included in Item 1 of Part I of this Form 10-Q. This
Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements involve risks and uncertainties.
All statements (other than statements of historical fact) included in this Form 10-Q that address activities, events or developments
that may occur in the future, the Trust’s operations, the Sponsor’s plans and references to the Trust’s future success
and other similar matters are forward-looking statements. Words such as “could,” “would,” “may,”
“expect,” “intend,” “estimate,” “predict,” and variations on such words or negatives
thereof, and similar expressions that reflect our current views with respect to future events and Trust performance, are intended to
identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties that
are difficult to predict and many of which are outside of our control, and actual results could differ materially from those discussed.
Forward-looking statements involve risks and uncertainties that could cause actual results or outcomes to differ materially from those
expressed therein. We express our estimates, expectations, beliefs, and projections in good faith and believe them to have a reasonable
basis. However, we make no assurances that management’s estimates, expectations, beliefs, or projections will be achieved or accomplished.
These forward-looking statements are based on assumptions about many important factors that could cause actual results to differ materially
from those in the forward-looking statements. We do not intend to update any forward-looking statements even if new information becomes
available or other events occur in the future, except as required by the federal securities law s.
Organization
and Trust Overview
The
21Shares Core Ethereum ETF (the “Trust”) is a Delaware statutory trust, formed on September 5, 2023, pursuant to the Delaware
Statutory Trust Act (“DSTA”). The Trust operates pursuant to an Amended and Restated Trust Agreement (the “Trust Agreement”).
The Trust is not registered as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company
Act”) and is not a commodity pool for purposes of the Commodity Exchange Act (“CEA”). The Trust is managed and controlled
by 21Shares US LLC (the “Sponsor”). The Sponsor is a limited liability company formed in the state of Delaware on June 16,
2021, and is a wholly owned subsidiary of Jura Pentium Inc., whose ultimate parent company is 21co Holdings Limited (formerly known as
Amun Holdings Limited). The Sponsor is not subject to regulation by the Commodity Futures Trading Commission (“CFTC”) as
a commodity pool operator with respect to the Trust, or a commodity trading advisor with respect to the Trust. The Trust is an exchange-traded
fund (“ETF”) that issues units of beneficial interest (the “Shares”) representing fractional undivided beneficial
interests in its net assets that trade on the Cboe BZX Exchange, Inc. (the “Exchange”). The Shares are listed for trading
on the Exchange under a ticker symbol “CETH”.
The
Sponsor served as the “Seed Capital Investor” to the Trust. On May 1, 2024, the Sponsor, in its capacity as Seed Capital
Investor, subject to certain conditions, purchased 2 Shares at a per-Share price of $50.00 (the “Seed Creation Baskets”).
Total proceeds to the Trust from the sale of these Seed Creation Baskets were $100. Delivery of the Seed Creation Baskets was made on
May 1, 2024.
On
June 18, 2024 (the “Seed Capital Purchase Date”), 21Shares US LLC, in its capacity as Seed Capital Investor, purchased
the initial Seed Creation Baskets comprising 20,000 Shares (the “Initial Seed Creation Baskets”). In its capacity as
the Seed Capital Investor, 21Shares US LLC has acted as a statutory underwriter in connection with this purchase. The total proceeds
to the Trust from the sale of the Initial Seed Creation Baskets were $340,739. On June 18, 2024, the Trust purchased ether with
the proceeds of the Initial Seed Creation Baskets by transacting with an Ether Counterparty to acquire ether on behalf of the Trust in
exchange for cash provided by 21Shares US LLC in its capacity as Seed Capital Investor. All ether acquired in connection with the Initial
Seed Creation Baskets is held by the ether Custodians.
The
Trust’s investment objective is to seek to track the performance of ether, as measured by the performance of the CME CF Ether-Dollar
Reference Rate—New York Variant (the “Index”), adjusted for the Trust’s expenses and other liabilities. CF Benchmarks
Ltd. is the administrator for the Index (the “Index Provider”). The Index is designed to reflect the performance of ether
in U.S. dollars. In seeking to achieve its investment objective, the Trust holds ether at its Custodians and values its Shares daily based
on the Index. The Trust is a passive investment vehicle and is not a leveraged product. The Sponsor does not actively manage the ether
held by the Trust.
The
Trust issues Shares only in Creation Units of 10,000 or multiples thereof. Creation Units are issued and redeemed in exchange for cash.
Individual Shares will not be redeemed by the Trust but are listed and traded on the Exchange under the ticker symbol “CETH.”
The Trust issues Shares in Creation Units on a continuous basis at the applicable NAV per Share on the creation order date.
The
Trust pays the unitary Sponsor Fee of 0.21% of the Trust’s ether holdings. The Sponsor Fee is paid by the Trust to the Sponsor
as compensation for services performed under the Trust Agreement. The Sponsor is waiving the entire Sponsor Fee for (i) a six-month period
which commenced on July 23, 2024 (the day the Trust’s Shares were initially listed on the Exchange), or (ii) the first $500 million
of Trust assets, whichever comes first.
The
Trust is an “emerging growth company” as that term is used in the Securities Act of 1933, as amended (the “Securities
Act”), and, as such, the Trust may elect to comply with certain reduced public company reporting requirements.
The
NAV of the Trust is used by the Trust in its day-to-day operations to measure the net value of the Trust’s assets. The NAV is calculated
on each Business Day and is equal to the aggregate value of the Trust’s assets less its liabilities based on the Index price. In
determining the NAV of the Trust on any Business Day, the Administrator calculates the price of the ether held by the Trust as of 4:00
p.m. ET on such day. The Administrator also calculates the “NAV per Share” of the Trust, which equals the NAV of the Trust
divided by the number of outstanding Shares. For purposes of making these calculations, a Business Day means any day other than a day
when the Exchange is closed for regular trading.
11
In
addition to calculating NAV and NAV per Share, for purposes of the Trust’s financial statements, the Trust determines the Principal
Market NAV and Principal Market NAV per Share on each valuation date for such financial statements. The determination of the Principal
Market NAV and Principal Market NAV per Share is identical to the calculation of NAV and NAV per Share, respectively, except that the
value of ether is determined using the fair value of ether based on the price in the ether market that the Trust considers its “principal
market” as of 4:00 p.m. ET on the valuation date, rather than using the Index.
NAV
and NAV per Share are not measures calculated in accordance with GAAP and are not intended as substitute for Principal Market and Principal
Market NAV per Share, respectively.
Critical
Accounting Estimates
The
financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States
of America. The preparation of these financial statements relies on estimates and assumptions that impact the Trust’s financial
position and results of operations. These estimates and assumptions affect the Trust’s application of accounting policies. Below
is a summary of accounting policies on cash and investment valuation. There were no material estimates involving a significant level
of estimation uncertainty that had or are reasonably likely to have had a material impact on the Trust’s financial condition used
in the preparation of the financial statements. In addition, please refer to Note 2 to the Financial Statements included in this report
for further discussion of the Trust’s accounting policies.
Cash
Cash
includes non-interest bearing, non-restricted cash maintained with one financial institution that does not exceed U.S. federally insured
limits.
Investment
Valuation
The
Trust’s policy is to value investments held at fair value. The Trust follows the provisions of ASC 820, Fair Value Measurements
(“ASC 820”). ASC 820 provides guidance for determining fair value and requires increased disclosure regarding the inputs
to valuation techniques used to measure fair value. ASC 820 determines fair value to be the price that would be received for ether in
a current sale, which assumes an exit price resulting from an orderly transaction between market participants on the measurement date.
ASC 820-10 requires the assumption that ether is sold in its principal market to market participants (or in the absence of a principal
market, the most advantageous market).
The
Trust utilizes an exchange traded price from the Trust’s principal market for ether as of 4:00 p.m. ET on the Trust’s financial
statement measurement date.
Results
of Operations
For
the Three Months ended on September 30, 2024*
Net
realized and change in unrealized loss on investment in ether for the three months ended September 30, 2024, was $(3,223,608) which includes
a net change in unrealized depreciation on investment in ether of $(3,222,608). Net realized and unrealized loss on investment in ether
for the period was driven by ether price depreciation from $3,423.00 per ether as of June 30, 2024 to $2,594.43 per ether as of September
30, 2024. Net increase in net assets resulting from operations was $ 12,240,686 for the period ended September 30, 2024, which consisted
of a net increase in the number of shares outstanding offset by the aforementioned net realized and change in unrealized loss on investment
in ether.
For
the period May 1, 2024 (initial seed creation) through September 30, 2024*
Net realized and change in
unrealized loss on investment in ether for the period May 1, 2024 (date of initial seeding) through September 30, 2024, was $(3,222,047)
which includes a net change in unrealized depreciation on investment in ether of $(3,222,047). Net realized and unrealized loss on investment
in ether for the period was driven by ether price depreciation from $3,483.68 per ether as of June 18, 2024 to $2,594.43 per ether as
of September 30, 2024. Net increase in net assets resulting from operations was $ 12,582,986 for the period ended September 30, 2024,
which consisted of a net increase in the number of shares outstanding offset by the aforementioned net realized and change in unrealized
loss on investment in ether.
* No
prior year comparative period has been provided as this is the first year of the Trust’s
operations.
12
Liquidity
and Capital Resources
The
Trust is not aware of any trends, demands, commitments, events, or uncertainties that are reasonably likely to result in material changes
to its liquidity needs. The Trust’s only ordinary recurring expense is the fee paid to the Sponsor at an annual rate of 0.21% of
the daily net asset value of the Trust. The Sponsor is waiving the entire Sponsor Fee for (i) a six-month period which commenced on July
23, 2024 (the day the Trust’s Shares were initially listed on the Exchange), or (ii) the first $500 million of Trust assets, whichever
comes first. In exchange for the Sponsor’s fee, the Sponsor has agreed to assume the ordinary fees and expenses incurred by the
Trust, including but not limited to the following: fees charged by Administrator, the Custodians, Transfer Agent and the Trustee, the
Marketing Fee, Cboe BZX Exchange listing fees, typical maintenance and transaction fees of the DTC, SEC registration fees, printing and
mailing costs, website fees, tax reporting fees, audit fees, license fees and expenses, up to $100,000 per annum in ordinary legal fees
and expenses. The Sponsor bears expenses in connection with the Trust’s organization and initial offering costs.
The
Sponsor is not required to pay any extraordinary or non-routine expenses. Extraordinary expenses are fees and expenses which are unexpected
or unusual in nature, such as legal claims and liabilities and litigation costs or indemnification or other unanticipated expenses. Extraordinary
fees and expenses also include material expenses which are not currently anticipated obligations of the Trust. The Trust will be responsible
for the payment of such expenses to the extent any such expenses are incurred. Routine operational, administrative, and other ordinary
expenses are not deemed extraordinary expenses. The Trust will sell ether on an as-needed basis to pay the Sponsor’s fee.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.